Retinoic Acid Enhances Foxp3 Induction Indirectly by Relieving Inhibition from CD4+CD44hi Cells

Immunity

Volumn 29, Issue 5, 2008, Pages 758-770

  Hill, Jonathan A ^a   Hall, Jason A ^b,c   Sun, Cheng Ming ^b   Cai, Qi ^d   Ghyselinck, Norbert ^d   Chambon, Pierre ^d   Belkaid, Yasmine ^b   Mathis, Diane ^a   Benoist, Christophe ^a  

^a JOSLIN DIABETES CENTER   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CNRS   (France)

Author keywords

CELLIMUNO; MOLIMMUNO

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 21; INTERLEUKIN 4; RETINOIC ACID; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; HOMEOSTASIS; IN VIVO STUDY; MEMORY CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD44; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HOMEOSTASIS; INTERFERON-GAMMA; INTERLEUKIN-4; INTERLEUKINS; MICE; MICE, INBRED C57BL; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TRETINOIN;

EID: 55549084247     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2008.09.018     Document Type: Article

References (54)

1. Abb J., Abb H., and Deinhardt F. Effect of retinoic acid on the spontaneous and interferon-induced activity of human natural killer cells. Int. J. Cancer 30 (1982) 307-310
2. Abb J., Abb H., and Deinhardt F. Retinoic acid suppression of human leukocyte interferon production. Immunopharmacology 4 (1982) 303-310
3. Altucci L., and Gronemeyer H. The promise of retinoids to fight against cancer. Nat. Rev. Cancer 1 (2001) 181-193
4. Apostolou I., and von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199 (2004) 1401-1408
5. Benson M.J., Pino-Lagos K., Rosemblatt M., and Noelle R.J. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204 (2007) 1765-1774
6. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., and Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
7. Cerwenka A., Bakker A.B., McClanahan T., Wagner J., Wu J., Phillips J.H., and Lanier L.L. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12 (2000) 721-727
8. Chambon P. The retinoid signaling pathway: Molecular and genetic analyses. Semin. Cell Biol. 5 (1994) 115-125
9. Chapellier B., Mark M., Bastien J., Dierich A., Lemeur M., Chambon P., and Ghyselinck N.B. A conditional floxed (loxP-flanked) allele for the retinoic acid receptor beta (RARbeta) gene. Genesis 32 (2002) 91-94
10. Chapellier B., Mark M., Garnier J.M., Dierich A., Chambon P., and Ghyselinck N.B. A conditional floxed (loxP-flanked) allele for the retinoic acid receptor gamma (RARgamma) gene. Genesis 32 (2002) 95-98
11. Chapellier B., Mark M., Garnier J.M., Lemeur M., Chambon P., and Ghyselinck N.B. A conditional floxed (loxP-flanked) allele for the retinoic acid receptor alpha (RARalpha) gene. Genesis 32 (2002) 87-90
12. Chen J.Y., Penco S., Ostrowski J., Balaguer P., Pons M., Starrett J.E., Reczek P., Chambon P., and Gronemeyer H. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J. 14 (1995) 1187-1197
13. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., and Wahl S.M. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 (2003) 1875-1886
14. Coombes J.L., Siddiqui K.R., Arancibia-Carcamo C.V., Hall J., Sun C.M., Belkaid Y., and Powrie F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204 (2007) 1757-1764
15. Elias K.M., Laurence A., Davidson T.S., Stephens G., Kanno Y., Shevach E.M., and O'Shea J.J. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111 (2008) 1013-1020
16. Fantini M.C., Becker C., Monteleone G., Pallone F., Galle P.R., and Neurath M.F. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172 (2004) 5149-5153
17. Floess S., Freyer J., Siewert C., Baron U., Olek S., Polansky J., Schlawe K., Chang H.D., Bopp T., Schmitt E., et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5 (2007) e38
18. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., and Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005) 329-341
19. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., and Rudensky A.Y. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445 (2007) 771-775
20. Herman A.E., Freeman G.J., Mathis D., and Benoist C. CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 199 (2004) 1479-1489
21. Hill J., Feuerer M., Tash K., Haxhinasto S., Perez J., Melamed R., Mathis D., and Benoist C. Foxp3 Transcription-Factor-Dependent and -Independent Regulation of the Regulatory T Cell Transcriptional Signature. Immunity 27 (2007) 786-800
22. Hsieh C.S., Zheng Y., Liang Y., Fontenot J.D., and Rudensky A.Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat. Immunol. 7 (2006) 401-410
23. Huehn J., Siegmund K., Lehmann J.C., Siewert C., Haubold U., Feuerer M., Debes G.F., Lauber J., Frey O., Przybylski G.K., Niesner U., de la Rosa M., Schmidt C.A., Brauer R., Buer J., Scheffold A., and Hamann A. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 199 (2004) 303-313
24. Iwata M., Hirakiyama A., Eshima Y., Kagechika H., Kato C., and Song S.Y. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21 (2004) 527-538
25. Kang S.G., Lim H.W., Andrisani O.M., Broxmeyer H.E., and Kim C.H. Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J. Immunol. 179 (2007) 3724-3733
26. Kim J.M., Rasmussen J.P., and Rudensky A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8 (2007) 191-197
27. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., and von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6 (2005) 1219-1227
28. Lin W., Haribhai D., Relland L.M., Truong N., Carlson M.R., Williams C.B., and Chatila T.A. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8 (2007) 359-368
29. Lufkin T., Lohnes D., Mark M., Dierich A., Gorry P., Gaub M.P., Lemeur M., and Chambon P. High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc. Natl. Acad. Sci. USA 90 (1993) 7225-7229
30. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., and Weaver C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 (2006) 231-234
31. Mantel P.Y., Kuipers H., Boyman O., Rhyner C., Ouaked N., Ruckert B., Karagiannidis C., Lambrecht B.N., Hendriks R.W., Crameri R., et al. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol. 5 (2007) e329
32. Mark M., Ghyselinck N.B., and Chambon P. Function of retinoid nuclear receptors: Lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu. Rev. Pharmacol. Toxicol. 46 (2006) 451-480
33. Mora J.R., Iwata M., Eksteen B., Song S.Y., Junt T., Senman B., Otipoby K.L., Yokota A., Takeuchi H., Ricciardi-Castagnoli P., et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 314 (2006) 1157-1160
34. Mucida D., Kutchukhidze N., Erazo A., Russo M., Lafaille J.J., and Curotto de Lafaille M.A. Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115 (2005) 1923-1933
35. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., and Cheroutre H. Reciprocal Th-17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid. Science 13 (2007) 56-60
36. Nicholson R.C., Mader S., Nagpal S., Leid M., Rochette-Egly C., and Chambon P. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. EMBO J. 9 (1990) 4443-4454
37. Pacholczyk R., Ignatowicz H., Kraj P., and Ignatowicz L. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity 25 (2006) 249-259
38. Purton L.E., Dworkin S., Olsen G.H., Walkley C.R., Fabb S.A., Collins S.J., and Chambon P. RARgamma is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation. J. Exp. Med. 203 (2006) 1283-1293
39. Reich M., Liefeld T., Gould J., Lerner J., Tamayo P., and Mesirov J.P. GenePattern 2.0. Nat. Genet. 38 (2006) 500-501
40. Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., Shimizu J., Takahashi T., and Nomura T. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212 (2006) 8-27
41. Salbert G., Fanjul A., Piedrafita F.J., Lu X.P., Kim S.J., Tran P., and Pfahl M. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity. Mol. Endocrinol. 7 (1993) 1347-1356
42. Schambach F., Schupp M., Lazar M.A., and Reiner S.L. Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur. J. Immunol. 37 (2007) 2396-2399
43. Schug T.T., Berry D.C., Shaw N.S., Travis S.N., and Noy N. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 129 (2007) 723-733
44. Stockinger B., and Veldhoen M. Differentiation and function of Th17 T cells. Curr. Opin. Immunol. 19 (2007) 281-286
45. Sun C.M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., and Belkaid Y. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204 (2007) 1775-1785
46. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
47. von Boehmer H. Oral tolerance: Is it all retinoic acid?. J. Exp. Med. 204 (2007) 1737-1739
48. Wan Y.Y., and Flavell R.A. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102 (2005) 5126-5131
49. Wei J., Duramad O., Perng O.A., Reiner S.L., Liu Y.J., and Qin F.X. Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 104 (2007) 18169-18174
50. Wong J., Mathis D., and Benoist C. TCR-based lineage tracing: No evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets. J. Exp. Med. (2007) in press
51. Wong J., Obst R., Correia-Neves M., Losyev G., Mathis D., and Benoist C. Adaptation of TCR repertoires to self-peptides in regulatory and nonregulatory CD4+ T cells. J. Immunol. 178 (2007) 7032-7041
52. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., Bates D.L., Guo L., Han A., Ziegler S.F., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126 (2006) 375-387
53. Yamagata T., Mathis D., and Benoist C. Self-reactivity in thymic double-positive cells commits cells to a CD8 alpha alpha lineage with characteristics of innate immune cells. Nat. Immunol. 5 (2004) 597-605
54. Ziegler S.F. FOXP3: Of mice and men. Annu. Rev. Immunol. 24 (2006) 209-226